Huang Peng, Wang Chun-You, Gou Shan-Miao, Wu He-Shui, Liu Tao, Xiong Jiang-Xin
Department of Pancreatic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, Wuhan, China.
World J Gastroenterol. 2008 Jun 28;14(24):3903-7. doi: 10.3748/wjg.14.3903.
To explore the method of isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma cell line PANC-1.
The PANC-1 cells were cultured in Dulbecco modified eagle medium F12 (1:1 volume) (DMEM-F12) supplemented with 20% fetal bovine serum (FBS). Subpopulation cells with properties of tumor stem cells were isolated from pancreatic adenocarcinoma cell line PANC-1 according to the cell surface markers CD44 and CD24 by flow cytometry. The proliferative capability of these cells in vitro were estimated by 3-[4,5-dimehyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide (MTT) method. And the tumor growth of different subpopulation cells which were injected into the hypodermisof right and left armpit of nude mice was studied, and expression of CD44 and CD24 of the CD44(+)CD24(+) cell-formed nodules and PANC-1 cells were detected by avidin-biotin-peroxidase complex (ABC) immunohistochemical staining.
The 5.1%-17.5% of sorted PANC-1 cells expressed the cell surface marker CD44, 57.8% -70.1% expressed CD24, only 2.1%-3.5% of cells were CD44(+) CD24(+). Compared with CD44(-)CD24(-) cells, CD44(+)CD24(+) cells had a lower growth rate in vitro. Implantation of 10(4) CD44(-)CD24(-) cells in nude mice showed no evident tumor growth at wk 12. In contrast, large tumors were found in nude mice implanted with 10(3) CD44(+)CD24(+) cells at wk 4 (2/8), a 20-fold increase in tumorigenic potential (P < 0.05 or P < 0.01). There was no obvious histological difference between the cells of the CD44(+)CD24(+) cell-formed nodules and PANC-1 cells.
CD44 and CD24 may be used as the cell surface markers for isolation of pancreatic cancer stem cells from pancreatic adenocarcinoma cell line PANC-1. Subpopulation cells CD44(+)CD24(+) have properties of tumor stem cells. Because cancer stem cells are thought to be responsible for tumor initiation and its recurrence after an initial response to chemotherapy, it may be a very promising target for new drug development.
探索从胰腺腺癌细胞系PANC-1中分离肿瘤干细胞并进行生物学分析的方法。
将PANC-1细胞培养于添加20%胎牛血清(FBS)的杜尔贝科改良伊格尔培养基F12(体积比1:1)(DMEM-F12)中。根据细胞表面标志物CD44和CD24,通过流式细胞术从胰腺腺癌细胞系PANC-1中分离出具有肿瘤干细胞特性的亚群细胞。采用3-[4,5-二甲基-2-噻唑基]-2,5-二苯基-2H-四氮唑溴盐(MTT)法评估这些细胞的体外增殖能力。研究不同亚群细胞接种到裸鼠左右腋窝皮下后的肿瘤生长情况,并通过抗生物素蛋白-生物素-过氧化物酶复合物(ABC)免疫组织化学染色检测CD44(+)CD24(+)细胞形成的结节及PANC-1细胞中CD44和CD24的表达。
分选得到的PANC-1细胞中,5.1%-17.5%表达细胞表面标志物CD44,57.8%-70.1%表达CD24,仅2.1%-3.5%的细胞为CD44(+)CD24(+)。与CD44(-)CD24(-)细胞相比,CD44(+)CD24(+)细胞在体外的生长速度较慢。给裸鼠接种10⁴个CD44(-)CD24(-)细胞,在第12周时未观察到明显的肿瘤生长。相反,给裸鼠接种10³个CD44(+)CD24(+)细胞,在第4周时(2/8)发现有大肿瘤形成,致瘤潜能增加20倍(P<0.05或P<0.01)。CD44(+)CD24(+)细胞形成的结节细胞与PANC-1细胞之间在组织学上无明显差异。
CD44和CD24可作为从胰腺腺癌细胞系PANC-1中分离胰腺癌干细胞的细胞表面标志物。CD44(+)CD24(+)亚群细胞具有肿瘤干细胞特性。由于癌症干细胞被认为是肿瘤起始及对化疗初始反应后复发的原因,因此它可能是新药研发中一个非常有前景的靶点。